Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers.

Keith RL, Blatchford PJ, Merrick DT, Bunn PA Jr, Bagwell B, Dwyer-Nield LD, Jackson MK, Geraci MW, Miller YE.

Cancer Prev Res (Phila). 2019 Oct;12(10):721-730. doi: 10.1158/1940-6207.CAPR-19-0006. Epub 2019 Jul 15.

PMID:
31308004
2.

Association between objective sleep duration and bone mineral density in older postmenopausal women from the Study of Osteoporotic Fractures (SOF).

Swanson CM, Blatchford PJ, Orwoll ES, Cauley JA, LeBlanc ES, Fink HA, Wright KP Jr, Wierman ME, Kohrt WM, Stone KL; Study of Osteoporotic Fractures (SOF).

Osteoporos Int. 2019 May 28. doi: 10.1007/s00198-019-05007-5. [Epub ahead of print]

PMID:
31139855
3.

Improving Physical Activity Through Adjunct Telerehabilitation Following Total Knee Arthroplasty: Randomized Controlled Trial Protocol.

Kline PW, Melanson EL, Sullivan WJ, Blatchford PJ, Miller MJ, Stevens-Lapsley JE, Christiansen CL.

Phys Ther. 2019 Jan 1;99(1):37-45. doi: 10.1093/ptj/pzy119.

PMID:
30329126
4.

Effects of Testosterone and Progressive Resistance Exercise on Vascular Function in Older Men.

Hildreth KL, Schwartz RS, Vande Griend J, Kohrt WM, Blatchford PJ, Moreau KL.

J Appl Physiol (1985). 2018 Sep 6. doi: 10.1152/japplphysiol.00165.2018. [Epub ahead of print]

PMID:
30188798
5.

Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer.

Karam SD, Reddy K, Blatchford PJ, Waxweiler T, DeLouize AM, Oweida A, Somerset H, Marshall C, Young C, Davies KD, Kane M, Tan AC, Wang XJ, Jimeno A, Aisner DL, Bowles DW, Raben D.

Clin Cancer Res. 2018 Oct 15;24(20):4949-4959. doi: 10.1158/1078-0432.CCR-18-0467. Epub 2018 Jul 3.

PMID:
30084837
6.

Response to Davis and Behm (doi: 10.1089/jpm.2017.0608): Discontinuation of Statins.

Ritchie CS, Kutner JS, Blatchford PJ, Abernethy AP.

J Palliat Med. 2018 Mar;21(3):283. doi: 10.1089/jpm.2017.0661. No abstract available.

PMID:
29649384
7.

Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life.

Hildreth KL, Ozemek C, Kohrt WM, Blatchford PJ, Moreau KL.

Menopause. 2018 Sep;25(9):1011-1019. doi: 10.1097/GME.0000000000001112.

8.

Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor.

Villalobos VM, Hall F, Jimeno A, Gore L, Kern K, Cesari R, Huang B, Schowinsky JT, Blatchford PJ, Hoffner B, Elias A, Messersmith W.

Ann Surg Oncol. 2018 Mar;25(3):768-775. doi: 10.1245/s10434-017-6082-1. Epub 2017 Sep 8.

PMID:
28887726
9.

High Symptom Burden and Low Functional Status in the Setting of Multimorbidity.

Portz JD, Kutner JS, Blatchford PJ, Ritchie CS.

J Am Geriatr Soc. 2017 Oct;65(10):2285-2289. doi: 10.1111/jgs.15045. Epub 2017 Aug 30. Erratum in: J Am Geriatr Soc. 2019 Jul;67(7):1536-1537.

10.

Patterns of fractionation for patients with T2N0M0 glottic larynx cancer undergoing definitive radiotherapy in the United States.

Stokes WA, Stumpf PK, Jones BL, Blatchford PJ, Karam SD, Lanning RM, Raben D.

Oral Oncol. 2017 Sep;72:110-116. doi: 10.1016/j.oraloncology.2017.07.013. Epub 2017 Jul 18.

PMID:
28797446
11.

Perceptions of Statin Discontinuation among Patients with Life-Limiting Illness.

Tjia J, Kutner JS, Ritchie CS, Blatchford PJ, Bennett Kendrick RE, Prince-Paul M, Somers TJ, McPherson ML, Sloan JA, Abernethy AP, Furuno JP.

J Palliat Med. 2017 Oct;20(10):1098-1103. doi: 10.1089/jpm.2016.0489. Epub 2017 May 18. Erratum in: J Palliat Med. 2019 Mar;22(3):351.

12.

Epidemiology of Infectious Disease-Related Death After Release from Prison, Washington State, United States, and Queensland, Australia: A Cohort Study.

Binswanger IA, Blatchford PJ, Forsyth SJ, Stern MF, Kinner SA.

Public Health Rep. 2016 Jul-Aug;131(4):574-82.

13.

Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma.

Merrick DT, Gao D, Miller YE, Keith RL, Baron AE, Feser W, Kennedy TC, Blatchford PJ, Braudrick S, Hirsch FR, Heasley L, Bunn PA Jr, Franklin WA.

Cancer Prev Res (Phila). 2016 Jan;9(1):96-104. doi: 10.1158/1940-6207.CAPR-15-0305. Epub 2015 Nov 5.

14.

Clinical risk factors for death after release from prison in Washington State: a nested case-control study.

Binswanger IA, Stern MF, Yamashita TE, Mueller SR, Baggett TP, Blatchford PJ.

Addiction. 2016 Mar;111(3):499-510.

15.

Perspectives of patients on factors relating to adherence to post-acute coronary syndrome medical regimens.

Lambert-Kerzner A, Havranek EP, Plomondon ME, Fagan KM, McCreight MS, Fehling KB, Williams DJ, Hamilton AB, Albright K, Blatchford PJ, Mihalko-Corbitt R, Bryson CL, Bosworth HB, Kirshner MA, Giacco EJ, Ho PM.

Patient Prefer Adherence. 2015 Jul 24;9:1053-9. doi: 10.2147/PPA.S84546. eCollection 2015.

16.

A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer.

Arcaroli JJ, Tai WM, McWilliams R, Bagby S, Blatchford PJ, Varella-Garcia M, Purkey A, Quackenbush KS, Song EK, Pitts TM, Gao D, Lieu C, McManus M, Tan AC, Zheng X, Zhang Q, Ozeck M, Olson P, Jiang ZQ, Kopetz S, Jimeno A, Keysar S, Eckhardt G, Messersmith WA.

Int J Cancer. 2016 Jan 1;138(1):195-205. doi: 10.1002/ijc.29676. Epub 2015 Jul 22.

17.

Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.

Goldenberg NA, Abshire T, Blatchford PJ, Fenton LZ, Halperin JL, Hiatt WR, Kessler CM, Kittelson JM, Manco-Johnson MJ, Spyropoulos AC, Steg PG, Stence NV, Turpie AG, Schulman S; Kids-DOTT Trial Investigators.

J Thromb Haemost. 2015 Sep;13(9):1597-605. doi: 10.1111/jth.13038. Epub 2015 Aug 11.

18.

Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.

Kutner JS, Blatchford PJ, Taylor DH Jr, Ritchie CS, Bull JH, Fairclough DL, Hanson LC, LeBlanc TW, Samsa GP, Wolf S, Aziz NM, Currow DC, Ferrell B, Wagner-Johnston N, Zafar SY, Cleary JF, Dev S, Goode PS, Kamal AH, Kassner C, Kvale EA, McCallum JG, Ogunseitan AB, Pantilat SZ, Portenoy RK, Prince-Paul M, Sloan JA, Swetz KM, Von Gunten CF, Abernethy AP.

JAMA Intern Med. 2015 May;175(5):691-700. doi: 10.1001/jamainternmed.2015.0289. Erratum in: JAMA Intern Med. 2015 May;175(5):869. Erratum in: JAMA Intern Med. 2019 Jan 1;179(1):126-127.

19.

Age-related differences in biomarkers of acute inflammation during hospitalization for sepsis.

Ginde AA, Blatchford PJ, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, Moretti E, Nguyen HB, Gunnerson KJ, Milzman D, Gaieski DF, Goyal M, Cairns CB, Rivers EP, Shapiro NI.

Shock. 2014 Aug;42(2):99-107. doi: 10.1097/SHK.0000000000000182.

20.

A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma.

De Jesus-Acosta A, Laheru D, Maitra A, Arcaroli J, Rudek MA, Dasari A, Blatchford PJ, Quackenbush K, Messersmith W.

Invest New Drugs. 2014 Aug;32(4):739-45. doi: 10.1007/s10637-014-0083-8. Epub 2014 Mar 27.

21.

Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009.

Binswanger IA, Blatchford PJ, Mueller SR, Stern MF.

Ann Intern Med. 2013 Nov 5;159(9):592-600. doi: 10.7326/0003-4819-159-9-201311050-00005.

22.

Oral iloprost improves endobronchial dysplasia in former smokers.

Keith RL, Blatchford PJ, Kittelson J, Minna JD, Kelly K, Massion PP, Franklin WA, Mao J, Wilson DO, Merrick DT, Hirsch FR, Kennedy TC, Bunn PA Jr, Geraci MW, Miller YE.

Cancer Prev Res (Phila). 2011 Jun;4(6):793-802. doi: 10.1158/1940-6207.CAPR-11-0057.

23.

Risk factors for all-cause, overdose and early deaths after release from prison in Washington state.

Binswanger IA, Blatchford PJ, Lindsay RG, Stern MF.

Drug Alcohol Depend. 2011 Aug 1;117(1):1-6. doi: 10.1016/j.drugalcdep.2010.11.029. Epub 2011 Feb 3.

PMID:
21295414
24.

The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control.

Bayliss EA, Blatchford PJ, Newcomer SR, Steiner JF, Fairclough DL.

J Gen Intern Med. 2011 Jun;26(6):575-81. doi: 10.1007/s11606-010-1600-x. Epub 2011 Jan 4.

Supplemental Content

Loading ...
Support Center